Patent · US Expired

Solid oral dosage forms of ifosfamide

US5158776A · kind A · utility

0Cited by
4References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 24, 1991
Grant dateOct 27, 1992
Priority date
Expiry dateJul 24, 2011

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Solid oral ifosfamide formulations comprising a capsule containing a mass which consists essentially of the active substance ifosfamide and microcrystalline cellulose, or in the form of tablets which contain, in relation to one part by weight of ifosfamide, PA0 0.1-1.0 parts by weight of tribasic calcium phosphate and PA0 0.04-0.4 parts by weight of polyethylene glycol as well as in addition, related to the weight of the tablet PA0 5-60% by weight of a filling and flow regulating agent PA0 1-10% by weight of a disintegrant PA0 0.1-10% by weight of an antiadhesion agent and PA0 0.1-80% by weight of a binding agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.